65 results
8-K
ALIM
Alimera Sciences Inc.
7 Mar 24
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results
8:32am
period may be extended an additional 12 months if Alimera meets certain financial targets by April 20, 2025.
The foregoing descriptions of the terms
8-K
EX-10.2
ALIM
Alimera Sciences Inc.
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
be final and binding. The Board and the Compensation Committee have discretion to modify the Revenue Targets or performance results to reflect … the Effective Date, provided however that any such modifications made with respect to the Revenue Targets or performance results related to the PSUs granted
8-K
EX-10.2
ALIM
Alimera Sciences Inc.
12 Dec 23
Departure of Directors or Certain Officers
5:09pm
the Revenue Targets or performance results to reflect significant transactions (such as acquisitions, divestitures, or newly-formed joint ventures
8-K
EX-10.1
uj2bg37anmiwuu82
3 Oct 23
Alimera Sciences Appoints Jason Werner as Chief Operating Officer
7:00am
8-K
k7l07
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
8-K
EX-99.1
hyrv3cq805 piemaaf77
31 Mar 23
Alimera Sciences Announces 2022 Financial Results and Business Update
8:43am
8-K
EX-10.1
imkcwg6j sdnzto9w5
16 Jun 21
Departure of Directors or Certain Officers
5:06pm